MiNK Therapeutics, Inc. (INKT) Misses Q4 EPS by 54c

MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q4 EPS of ($0.62), $0.54 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
• Neotech Metals closes $3.08M private placement